Table 1.
Characteristic | Probands (n = 95) | Relatives (n = 29) |
---|---|---|
Sex | ||
Male | 34 (36) | 13 (44) |
Female | 61 (64) | 16 (55) |
Age, y | ||
Mediana | 33 | 36 |
Range | 8-86 | 6-86 |
IQR | 22-40 | 18-59 |
Race | ||
White | 73 (76) (n = 46 female) | 23 (80) (n = 13 female) |
Black | 3 (3) (n = 3 female) | |
Asian | 2 (2) (n = 2 male) | |
Unknown or multiracial | 15 (15) (n = 11 female) | 3 (10) (n = 2 female) |
American native | 2 (n = 1 female) | 3 (10) (n = 1 female) |
Pulmonary alveolar proteinosis | 11 | 0 |
Pulmonary function tests | ||
FEV1, % predicted | 82 (24-121) | 94 (60-113) |
FVC, % predicted | 92 (37-129) | 96 (83-120) |
Dlco adjusted for hemoglobin, % predicted | 63 (31-111) | 76 (54-115) |
Myelodysplasia or monocytopenia | 42 (44) | 4 (14) |
Nontuberculous mycobacteria | 42(44) | 0 |
Viral infection (including warts) | 70 (73) | 16 (55) |
Fungal infection | 24 (25) | 3 (10) |
Malignancy (other than myelodysplasia or leukemia) | 11 (11) | 1 (0.3) |
Bone marrow transplantation | 58 (61) | 7 (24) |
Data are presented as No. (%), No., or median (range), unless otherwise indicated. Dlco = diffusing capacity for carbon monoxide; IQR = interquartile range.
Median age reflects all patients alive at time of report. Those who underwent transplantation were censored at the time of hematopoietic stem cell transplantation.